Mean SUVs in Patients at Baseline and at 4 Cycles of Induction Chemotherapy
| PET4 | ||||
|---|---|---|---|---|
| Type of measurement | PET0 total (n = 92) | Total (n = 80) | PET4-positive (n = 18) | PET4-negative (n = 62) |
| SUVmax | 13.2 ± 4.8 (4.8–24.8) | 2.9 ± 2.7 (0.8–20.9) | 5.7 ± 4.7 (1.6–20.9) | 2.1 ± 0.8 (0.8–4.8) |
| SUVmax reduction PET0–4 (%) | — | 76.7 ± 17.9 (−8.6–96.2) | 56.5 ± 25.7 (−8.6–84.6) | 82.6 ± 8.5 (51.7–96.2) |